Waterloo researcher studies innovative approach to cancer treatment with
new funding from Canadian Cancer Society
WATERLOO, ON, July 25, 2012 /CNW/ - The Canadian Cancer Society has
granted new funding to a Waterloo scientist to research an innovative
fresh approach to cancer treatment.
Photodynamic therapy is a new technology that uses a combination of
light and light-sensitive drugs to kill cancer cells. While it is
currently used to treat some types of cancer, there are limitations
that prevent more widespread use of this therapy, such as the ability
of light to reach tumours deep inside the body.
Dr Qing-Bin Lu of the University of Waterloo has been granted nearly
$200,000 for an innovative approach aimed to improve this therapy. He
will examine the use of a novel light-controlled agent in combination
with low doses of a currently used cancer drug called cisplatin. The
interaction between these two therapies has only recently been
discovered and has not yet been explored in great detail.
By applying this new approach, photodynamic therapy could become a more
wide-spread treatment option in clinical practice, especially for those
cancers that are currently hard to treat with this therapy.
Dr Lu's use of leading edge techniques to study this new approach to
photodynamic therapy was recognized as highly innovative. Dr Lu is one
of 15 Ontario scientists to receive new funding for unique and creative
research, the Canadian Cancer Society announced today.
"Ontario continues to produce innovative research that ranks among the
best in the world. We are proud to support these new projects because
they bring a unique perspective in our fight against cancer," says Mary
Argent-Katwala, Director, Research, Canadian Cancer Society. "We keenly
anticipate the impact that the research will have on the lives of all
The Society's Innovation Grants were developed to support innovative and
creative problem-solving in cancer research. The goal is to support
unconventional concepts, approaches or methodologies to address
problems in cancer research.
A total of 28 grants representing a $5.4 million investment across the
country were announced today. The Canadian Cancer Society is the
largest charitable funder of cancer research in Canada. For more
information about the Society's research funding, visit www.cancer.ca.
The Canadian Cancer Society is a national community-based organization
of volunteers whose mission is the eradication of cancer and the
enhancement of the quality of life of people living with cancer. When
you want to know more about cancer, visit our website www.cancer.ca or call our toll-free, bilingual Cancer Information Service at 1 888 939-3333.
SOURCE: Canadian Cancer Society (Ontario Division)
For further information:
Canadian Cancer Society, Ontario Division
(416) 323-7030; email@example.com